TWC
AIM

TD Waterhouse Canada’s AIM ImmunoTech AIM Stock Holding History

TD Waterhouse Canada’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$20 – 2126
2025
Q1 		$20 Hold
2
– – ﹤0.01% 1910
2024
Q4 		$33 Hold
2
– – ﹤0.01% 1926
2024
Q3 		$43 Hold
2
– – ﹤0.01% 1847
2024
Q2 		$63 Buy
+2
New +$85 ﹤0.01% 1851
2024
Q1 		– Sell
-2
Closed -$107 – 2005
2023
Q4 		$107 Hold
2
– – ﹤0.01% 1654
2023
Q3 		$105 Hold
2
– – ﹤0.01% 1661
2023
Q2 		$150 Hold
2
– – ﹤0.01% 1691
2023
Q1 		$96 Hold
2
– – ﹤0.01% 1702
2022
Q4 		$73 Hold
2
– – ﹤0.01% 1671
2022
Q3 		$134 Hold
2
– – ﹤0.01% 1669
2022
Q2 		$171 Hold
2
– – ﹤0.01% 1702
2022
Q1 		$226 Hold
2
– – ﹤0.01% 1736
2021
Q4 		$220 Buy
+2
New +$309 ﹤0.01% 1706

Other funds holding AIM

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

TD Waterhouse Canada's AIM Position: Q2 2025 in Review

TD Waterhouse Canada sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 2 shares — an estimated $20 sold.

TD Waterhouse Canada first reported a position in AIM in Q4 2021 and held it in 13 quarters. The position peaked at $226 in Q1 2022. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • TD Waterhouse Canada reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 2 AIM ImmunoTech shares in Q2 2025, an estimated $20.
  • TD Waterhouse Canada first reported a position in AIM ImmunoTech in Q4 2021 and held it in 13 quarters.
  • TD Waterhouse Canada's AIM ImmunoTech position peaked at $226 in Q1 2022.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on TD Waterhouse Canada's 13F filing for Q2 2025, filed 11 Aug 2025.